Articles tagged with Hemodialysis
A national wildfire risk assessment found 30% of dialysis facilities within 5km of wildfires, serving 2/3 of Canadians receiving in-centre hemodialysis. Poor air quality can further harm patients, with 64% of facilities in high, very high, or extreme wildfire risk areas.
A new hybrid optical system noninvasively tracks tissue water dynamics during hemodialysis, identifying early signs of patient instability. The system uses near-infrared spectroscopy to gather data on tissue water content and other physiological signals, providing a high-resolution portrait of the optical properties of tissue.
Researchers developed a highly sensitive blood test that can detect initial thrombin generation, a key trigger in blood clot formation. The test distinguishes between pathway-specific clotting abnormalities and suggests personalized treatment strategies, potentially predicting clinical outcomes.
A culturally tailored intervention utilizing community health workers has been shown to improve dialysis adherence among Hispanic and Latino patients. The Navigate-Kidney program provides patient-centered education, support, and empowerment, leading to a modest reduction in interdialytic weight gain.
The navigate-kidney study finds that community health workers enhance holistic, patient-centered care through improved patient engagement and emotional wellbeing. This integration into dialysis care teams may lead to better outcomes for patients with kidney failure.
A culturally tailored community health worker intervention modestly lowered interdialytic weight gain and improved dialysis adherence among Hispanic and Latino patients with hemodialysis-dependent kidney failure. This study suggests that such interventions can enhance patient outcomes for these vulnerable populations.
A new study estimates that about 14% of adults worldwide have chronic kidney disease, with 1.5 million deaths in 2023. Early detection and treatment are crucial to prevent severe interventions like dialysis and transplantation.
A conservative dialysis approach resulted in faster and more complete kidney function recovery in patients with acute kidney injury. The study's findings suggest that this strategy could be a viable option for treating dialysis-requiring AKI, warranting further investigation.
Researchers at Mayo Clinic found that transplanting patients' own stem cells into their veins can help prevent inflammation and vein narrowing in patients with end-stage kidney disease. This could extend the time before dialysis is required, reducing healthcare costs and improving patient outcomes.
A retrospective cohort study found system-based disparities in pre-dialysis nephrology care contribute to 1/3 of incident vascular access disparities among Hispanics. Targeted policies are needed to improve timely identification and referrals for equitable improvements in kidney failure outcomes.
A new randomized controlled trial found that pain coping skills training (PCST) significantly reduced chronic pain in dialysis patients, enabling them to perform daily activities with less interference. PCST, a 12-week coaching session followed by automated voice response sessions, addressed pain-related anxiety and stress.
A new nanotechnology-based drug delivery system has been developed to save patients from repeated surgeries. The approach, called Pericelle, uses a paste of nanoparticles containing hydrogel on transplanted veins to prevent blockages, which can lead to repeated surgeries in heart and dialysis patients.
A 12-week randomized controlled trial found that IDPN using ENEFLUID increased energy intake from food and reduced hypoglycemia during dialysis, suggesting potential benefits for malnourished hemodialysis patients. However, the study did not demonstrate direct improvements in nutritional markers.
Researchers have found dialysis to be 'astonishingly effective' in separating salts from organic substances in wastewater, reducing environmental impacts and costs. The method mimics medical dialysis technology, eliminating the need for repeated dilutions and fouling, and enabling resource recovery.
A clinical trial funded by the NIH found that pain coping skills training reduced pain interference, improved mood, and enhanced quality of life in adults with end-stage kidney disease undergoing hemodialysis. The intervention was adapted for patients with limited pain treatment options and showed benefits comparable to opioids.
Pain coping skills training significantly reduced pain interference in patients undergoing hemodialysis, with a substantial proportion experiencing clinically meaningful improvements. The intervention had modest but beneficial effects on other pain-associated outcomes.
Researchers at the University of British Columbia have developed a groundbreaking coating that mimics natural blood vessels to reduce clotting and bleeding risks. The coating's unique properties prevent clot formation without disrupting normal blood functions, offering a promising alternative to high-risk blood thinners.
A study published in JAMA found that personalized recommendations for hospitalized patients with acute kidney injury did not improve outcomes. Despite higher implementation rates in the intervention group, worsening acute kidney injury stage, dialysis, or mortality remained unchanged.
For some older adults with kidney failure, waiting to start dialysis when their eGFR falls below a certain threshold can prolong life by roughly one week. However, this approach also means spending more time in hospitals or care facilities.
A UCLA-led team created a machine-learning model that can accurately predict short-term CRRT survival, providing a data-driven tool for clinical decision-making. The study aims to improve patient outcomes and resource use by serving as a basis for future clinical trials.
A study found that pay-for-performance incentives increased home dialysis use and kidney transplant rates. The End-Stage Renal Disease Treatment Choices model did not associate these outcomes with changes in racial or socioeconomic disparities.
A new study published in JAMA suggests that kidneys from deceased donors on dialysis can be safely transplanted into recipients, reducing the pool of available donors. The study found no significant difference in transplant failure or death rates between recipients of kidneys from donors with and without dialysis.
Receiving a kidney from a deceased donor who underwent dialysis prior to donation was associated with delayed graft function, while other factors such as graft failure and death were not significantly affected. The study found no significant differences in outcomes between these two groups.
A recent study found that treatment with intravenous acetaminophen for 5 days in critically ill sepsis patients was safe, but did not improve the primary end point of days alive and free of organ support. The study suggests acetaminophen may have a role in preventing or treating organ dysfunction in sepsis.
Researchers at NTU Singapore successfully grew 'mini kidneys' in the lab, grafted them into live mice, and found a potential treatment for polycystic kidney disease by boosting autophagy. The study suggests that minoxidil could be used to reduce cysts in the novel mouse model.
Researchers discovered that known genetic variants account for a large portion of chronic kidney diseases with unknown origin. The study found that 10% of patients had pathogenic variants in CKD-causing genes, and some hereditary renal diseases could be diagnosed and treated early on to slow down disease progression.
Researchers at Rensselaer Polytechnic Institute have developed a patented process to produce heparin in the lab, offering a consistent and safe supply of the essential medicine. The discovery has the potential to revolutionize the production of heparin, reducing reliance on animal-derived sources and addressing global supply chain issues.
Researchers at the University of Virginia Health System are developing a technique to 'paint' tiny nanoparticles on transplanted veins to prevent blockages, potentially sparing patients from repeated surgeries. This approach could significantly reduce the number of vascular reconstructions performed annually in the US.
A new University of Cincinnati study compares pregnancy rates in patients on two types of dialysis, finding a higher rate with home hemodialysis. The study found an overall pregnancy rate of almost 9 people per thousand, with black women and younger age associated with a higher likelihood of pregnancy.
A new study found that dialysis facilities serving high-risk populations are more likely to receive lower reimbursement under the End-Stage Renal Disease Treatment Choices Model. The rate of home dialysis and transplant waitlisting is also lower among these facilities.
A new study tested cognitive behavioral therapy and trazodone for treating sleeplessness in dialysis patients, finding no meaningful difference in symptoms. The researchers suggest that multiple medical conditions and medication interactions may be driving the insomnia.
A clinical trial found that trazodone and cognitive behavioral therapy for insomnia were no more effective than placebo in improving insomnia symptoms among long-term dialysis patients. Serious adverse events also occurred more frequently with trazodone use. More trials are needed to investigate additional therapies for this condition.
A clinical trial found that an experimental drug, BI 690517, reduced albuminuria in 70% of patients when paired with a standard-care medication. The study also showed that the combination of the two drugs mitigated the risk of hyperkalemia.
Researchers from Tokyo Medical and Dental University found that people admitted to the hospital for acute hypertension are increasingly likely to need urgent kidney dialysis or die in the hospital. The study's lead author notes that patients with certain traits, such as being younger, male, or overweight, are high-risk groups.
A study of 25,000 veterans revealed that unstable housing before starting dialysis was associated with a higher risk of all-cause mortality. The risks were found to increase with age, highlighting the need for further research on this vulnerable population.
A potential treatment for Haemolytic Uraemic Syndrome (HUS) has been discovered by an international team of scientists. The breakthrough found that inhibiting the complement pathway early on can successfully treat STEC-HUS, a devastating disease that can lead to life-long dialysis and death in children.
A study by UC San Francisco researchers found that patients with acute kidney injury on outpatient dialysis may not need lifelong treatment if they have the potential to recover. The study tracked data from over 1,700 patients and showed that approximately three-quarters of those who recovered kidney function discontinued dialysis with...
Over 75% of hospitalized AKI patients lack proper follow-up kidney health testing after discharge. Less than 25% have kidney function monitored with blood and urine tests within 90 days of discharge.
A recent study published in the American Journal of Kidney Diseases found that lower uromodulin levels are associated with a higher risk of developing end-stage kidney disease. Participants who experienced steeper declines in uromodulin also showed an increased risk of kidney failure.
Scientists at UCSF have developed an artificial kidney that can mimic key functions of a real kidney. The bioreactor keeps kidney cells alive for up to seven days and has shown promising results in animal trials. If successful, the device could improve treatment for kidney disease, making it more effective, tolerable, and comfortable.
This study highlights significant disparities in preoperative hemodialysis timing among patients with end-stage kidney disease, impacting surgical outcomes. The findings suggest a need to address equity in surgical care for these patients, particularly those from disadvantaged backgrounds.
A large-scale study found that exercise programs for dialysis patients lead to significant improvements in physical fitness, quality of life, and reduced hospital stays. Personalized exercise plans showed low costs per training unit, making them a viable option for standard healthcare coverage.
Researchers identified a new drug treatment option for peritonitis in patients on peritoneal dialysis, showing that a low dosage of ceftazidime and avibactam is sufficient to treat the infection. The study's findings could help gain control over peritonitis in patients with difficult-to-treat germs.
A new patient-guided intervention using telemedicine has been shown to improve symptoms of fatigue, pain, and depression in dialysis patients. The Technology Assisted Stepped Collaborative Care (TĀCcare) trial found significant improvements in energy levels and pain severity that persisted for six months after treatment.
A new study published in the New England Journal of Medicine found that high-dose haemodiafiltration reduces mortality in kidney failure patients by 23%. The CONVINCE trial compared two treatments and showed that wider use of high-dose haemodiafiltration would have clear benefits for patients.
A clinical trial using DIALIVE, a novel liver dialysis device, demonstrated significant improvements in all main underlying pathophysiological mechanisms of acute-on-chronic liver failure. Treatment resulted in accelerated resolution of ACLF and sustained improvement in biomarkers.
A growing number of states have implemented policies to cover outpatient hemodialysis for undocumented immigrants with kidney failure. This expansion may be due to increased awareness of poor outcomes with emergency hemodialysis and advocacy efforts. The move towards covering dialysis in all 50 states is called for by experts, who also...
Researchers at Wake Forest University School of Medicine aim to improve hemodialysis quality with an individualized approach, tailoring treatments to each patient's unique medical needs. The project aims to reduce mortality and improve health-related quality of life for patients treated with hemodialysis.
Researchers identified a higher rate of premature arteriovenous graft failure among African American patients undergoing dialysis access interventions. The study, published in Radiology, found that these patients were more vulnerable to experiencing early dialysis access dysfunction and failure.
Researchers analyzed electronic health record data from over 7.1 million children to identify risk factors associated with a faster decline in kidney function, including disease origin, proteinuria, hypertension, and younger age. The study found that certain attributes are linked to a more rapid decline in kidney function, providing va...
Researchers propose a new hypothesis for developing small diameter vascular grafts (SDVG) that heal in a reconstructive manner. They aim to emulate the structure and behavior of living arteries, incorporating a blood vessel network within the graft walls.
A recent study validated a remote access monitoring technology that predicts vascular access blockages in dialysis patients. The Vasc-Alert technology, developed by Henry Ford Hospital clinicians, shows promise in reducing thrombotic episodes and healthcare costs associated with dialysis access failures.
A recent study examines the environmental sustainability practices of dialysis facilities in Australia and New Zealand, revealing multiple areas for improvement. The survey-based study identified opportunities to reduce waste and resource consumption, with only 33% of facilities responding to the survey indicating a lack of prioritizat...
Two new studies found that dialysis facilities owned by nephrologists may provide better care, with patients receiving home dialysis more often. Additionally, a shorter interval between dialysis and surgery was associated with improved post-surgery survival rates.
A study published in the New England Journal of Medicine found that new onset CKD rates are higher among Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations compared to white persons with diabetes. The rate declined from 8% in 2015-2016 to 6.4% in 2019-2020.
Researchers found a significant association between NTM infection and increased mortality in patients with end-stage renal disease. Early diagnosis and treatment may improve survival. NTM can cause nonspecific symptoms like fever and weight loss, and patients with compromised immune systems are at higher risk.
A retrospective cross-sectional study found that VA-financed hospice services were associated with higher rates of concurrent dialysis among veterans with end-stage kidney disease. Patients who received VA-financed hospice services lived approximately 43 days after stopping dialysis, compared to just four days for those who stopped dia...
A study found that in people with significant kidney disease, psoriasis does not increase the risk of heart attack. After controlling for other risk factors, researchers found no association between psoriasis and heart attacks in patients with end-stage renal disease.
Researchers from Osaka University found that serum albumin can prevent the formation of amyloid fibrils in dialysis patients by interfering with β2m protein clumping. Monitoring serum albumin levels may help predict and delay the onset of dialysis-related amyloidosis, a condition also linked to Alzheimer's disease.
A national US kidney disease registry found that 60% of participants were unaware of their kidney function level, hindering clinical trial recruitment. The National Kidney Foundation Patient Network aims to address this issue through real-world data collection and patient-centered research.